Phibro Animal Health Co. (NASDAQ:PAHC) to Issue Quarterly Dividend of $0.12

Phibro Animal Health Co. (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, November 5th,Zacks Dividends reports. Stockholders of record on Wednesday, November 27th will be paid a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.99%. The ex-dividend date of this dividend is Wednesday, November 27th.

Phibro Animal Health has a dividend payout ratio of 31.2% meaning its dividend is sufficiently covered by earnings. Analysts expect Phibro Animal Health to earn $1.90 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.3%.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $24.14 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The stock has a market cap of $977.67 million, a PE ratio of 56.14, a PEG ratio of 0.61 and a beta of 0.51. The company’s fifty day moving average is $23.22 and its 200 day moving average is $20.07. Phibro Animal Health has a 52 week low of $9.49 and a 52 week high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.34 by $0.07. The firm had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Research analysts anticipate that Phibro Animal Health will post 1.61 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director E Thomas Corcoran acquired 5,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the transaction, the director now owns 25,000 shares in the company, valued at $500,500. The trade was a 25.00 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 50.07% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on PAHC shares. Barclays increased their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 20th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective for the company. Finally, Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $16.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.